Nyxoah (NASDAQ: NYXH)
Nyxoah Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nyxoah Company Info
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Nyxoah S.A. (NYXH) Q2 2022 Earnings Call Transcript
NYXH earnings call for the period ending June 30, 2022.
Nyxoah S.A. (NYXH) Q1 2022 Earnings Call Transcript
NYXH earnings call for the period ending March 31, 2022.
Nyxoah S.A. (NYXH) Q4 2021 Earnings Call Transcript
NYXH earnings call for the period ending December 31, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.